Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines

通过人类单细胞分子网络识别恢复力的起源,然后在多样化、有恢复力的人类 IPS 系中对其进行测试

基本信息

  • 批准号:
    10474954
  • 负责人:
  • 金额:
    $ 49.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-30 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Much of late-life cognitive decline cannot be explained by Alzheimer’s disease (AD) or other common age- related neuropathologies. In fact, every individual is either resilient or susceptible to AD to a certain extent, due to their unique genetics and environment. Over the past 15 years our center has identified numerous environmental and psychological risk factors associated with faster or slower cognitive decline, and several molecular markers of resilience, that point to the existence of molecular networks that underlie resilience. The proposed project builds on this prior work. The overall goal of this proposal is to define the complex molecular basis of resilience to AD, using brains with various levels of resilience and in vitro human model systems, to identify novel therapeutic targets for cognitive decline. To do this, we will take a genome-wide approach to identify key molecular drivers of resilience in specific cell types in the human brain. Then we will perform rigorous tests of the molecules we have identified using brain cells from many different humans. Specifically we will see if we can genetically stimulate these cells to become more resilient to the effects of aging and Alzheimer’s disease. Two key innovations separate this project from previous work. The first aspect is our focus on individual cell types. Typically molecular measurements of brain data contain a mixture of dozens of cell types. We will measure each of these cell types individually, using single-cell RNAseq (scRNAseq), to identify which cell types are most related to resilience to AD. Within these specific cell types we will use computational network analysis to identify a smaller number of gene genes within the molecular systems affecting resilience. These predictions facilitate the 2nd aspect of this study which is unusual, which is our plan to change these genes in a human model of AD. The model we will use are neurons and glial cells derived from 50 individuals with different level of resilience to the common sporadic form of Alzheimer’s. We will use genome engineering to affect the abundance of genes that we predict are related to resilience in all of these cell lines. In this way we can check for resulting gene expression signatures of resilience as well as cellular phenotypes associated with health cognition, which persist in the face of AD pathology. The proposed project will deliver a comprehensive set of molecular networks and key molecules that underlie resilience to AD and other common brain pathologies. It will do so by breaking common barriers to progress in this area: 1) accurate identification of targets through a single cell approach and computational network methods, and 2) testing in realistic human models. The proposed project will provide high-confidence targets for therapeutic development. Thus, the proposal will have a strong and sustained impact on the field.
项目摘要 老年认知能力下降的大部分不能用阿尔茨海默病(AD)或其他常见的年龄来解释, 相关神经病理学。事实上,每个人在一定程度上都对AD有弹性或易感性, 因为他们独特的基因和环境。在过去的15年里,我们的中心已经确定了许多 与更快或更慢的认知衰退相关的环境和心理风险因素,以及一些 弹性的分子标记,指出弹性基础的分子网络的存在。的 该项目建立在这项工作的基础上。本提案的总体目标是定义综合体 抗AD能力的分子基础,使用具有不同抗AD能力水平的大脑和体外人类 模型系统,以确定新的治疗目标的认知能力下降。为此,我们将采取 全基因组方法来确定人类大脑中特定细胞类型的弹性的关键分子驱动因素。 然后,我们将对我们已经确定的分子进行严格的测试,使用来自许多不同脑细胞的脑细胞。 人类具体来说,我们将看看我们是否可以通过基因刺激这些细胞,使其对环境变得更有弹性。 老年痴呆症的影响。两个关键的创新将这个项目与以前的工作分开。的 第一个方面是我们专注于单个细胞类型。通常,大脑数据的分子测量包含 几十种细胞类型的混合物。我们将分别测量每种细胞类型,使用单细胞 RNAseq(scRNAseq),以鉴定哪些细胞类型与对AD的恢复力最相关。在这些具体 细胞类型,我们将使用计算网络分析,以确定一个较小数量的基因内的基因 影响恢复力的分子系统这些预测有助于本研究的第二个方面, 这是不寻常的,这是我们的计划,改变这些基因在人类模型的AD。我们将使用的模型是 神经元和神经胶质细胞来自50个不同水平的恢复能力的共同散发 老年痴呆症的症状我们将使用基因组工程来影响我们预测的基因丰度, 与这些细胞系的弹性有关。通过这种方式,我们可以检查产生的基因表达签名 弹性以及与健康认知相关的细胞表型,这些表型在AD面前持续存在 病理拟议的项目将提供一套全面的分子网络和关键分子 这是抗AD和其他常见脑部疾病的基础。它将通过打破共同的障碍来做到这一点 在这一领域取得进展:1)通过单细胞方法和计算方法准确识别目标 网络方法; 2)在真实人体模型中进行测试。该项目将提供高置信度 治疗发展的目标。因此,该提案将对实地产生强有力的持续影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher A. Gaiteri其他文献

Christopher A. Gaiteri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher A. Gaiteri', 18)}}的其他基金

AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learning
AIM-AI:通过深度学习绘制阿尔茨海默病的可操作、集成和多尺度遗传图谱
  • 批准号:
    10668829
  • 财政年份:
    2023
  • 资助金额:
    $ 49.9万
  • 项目类别:
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
确定赋予阿尔茨海默病突触弹性的治疗靶点
  • 批准号:
    10412994
  • 财政年份:
    2018
  • 资助金额:
    $ 49.9万
  • 项目类别:
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
确定赋予阿尔茨海默病突触弹性的治疗靶点
  • 批准号:
    10201513
  • 财政年份:
    2018
  • 资助金额:
    $ 49.9万
  • 项目类别:
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines
通过人类单细胞分子网络识别恢复力的起源,然后在多样化、有恢复力的人类 IPS 系中对其进行测试
  • 批准号:
    10655579
  • 财政年份:
    2018
  • 资助金额:
    $ 49.9万
  • 项目类别:
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines
通过人类单细胞分子网络识别恢复力的起源,然后在多样化、有恢复力的人类 IPS 系中对其进行测试
  • 批准号:
    9950958
  • 财政年份:
    2018
  • 资助金额:
    $ 49.9万
  • 项目类别:
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines
通过人类单细胞分子网络识别恢复力的起源,然后在多样化、有恢复力的人类 IPS 系中对其进行测试
  • 批准号:
    10730100
  • 财政年份:
    2018
  • 资助金额:
    $ 49.9万
  • 项目类别:
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience
识别认知弹性背后的分子系统、网络和关键分子
  • 批准号:
    9439572
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
Molecular Networks Underlying Resilience to Alzheimer's Disease Among APOE E4 Carriers
APOE E4 携带者对阿尔茨海默病的抵抗力的分子网络
  • 批准号:
    10188369
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience
识别认知弹性背后的分子系统、网络和关键分子
  • 批准号:
    10729301
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience
识别认知弹性背后的分子系统、网络和关键分子
  • 批准号:
    10229602
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 49.9万
  • 项目类别:
Parkinson's disease and aging affect neural activation during continuous gait alterations to the split-belt treadmill: An [18F] FDG PET Study.
帕金森病和衰老会影响分体带跑步机连续步态改变期间的神经激活:[18F] FDG PET 研究。
  • 批准号:
    400097
  • 财政年份:
    2019
  • 资助金额:
    $ 49.9万
  • 项目类别:
The elucidation of the mechanism by which intestinal epithelial cells affect impaired glucose tolerance during aging
阐明衰老过程中肠上皮细胞影响糖耐量受损的机制
  • 批准号:
    19K09017
  • 财政年份:
    2019
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Does aging of osteocytes adversely affect bone metabolism?
骨细胞老化会对骨代谢产生不利影响吗?
  • 批准号:
    18K09531
  • 财政年份:
    2018
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Links between affect, executive function, and prefrontal structure in aging: A longitudinal analysis
衰老过程中情感、执行功能和前额叶结构之间的联系:纵向分析
  • 批准号:
    9766994
  • 财政年份:
    2018
  • 资助金额:
    $ 49.9万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
  • 批准号:
    9925164
  • 财政年份:
    2016
  • 资助金额:
    $ 49.9万
  • 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
  • 批准号:
    9345997
  • 财政年份:
    2016
  • 资助金额:
    $ 49.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了